This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2025 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Jessica Longo
Director of Patient Support, Cardiometabolic and PAP at Novo Nordisk
Speaker

Profile

Jessica Longo is the Director of Cardiometabolic Patient Support and NNI Patient Assistance Programs (PAP) at Novo Nordisk. Jessica has over a decade of pharmaceutical marketing and patient support experience across many disease states within the pharmaceutical industry, for companies including Shire and Takeda. She started her journey with patient services as the Patient Marketing Lead at Shire, and enjoys bringing those learnings from rare disease to her work helping support patients in other, larger disease areas. Having worked in marketing on multiple product launches, and products further in their lifecycle, Jessica has a true passion for supporting patients along their entire treatment journey, and is constantly striving to create a better patient experience. Jessica holds a Bachelor of Arts in Communications from Villanova University.

Agenda Sessions

  • Leaders Council Insight—Unravelling the Complexities of Patient Access and Affordability

    11:00am